
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz
US: In a stern regulatory move, the United States Food and Drug Administration (USFDA) has issued a warning letter to Virginia-based Sarfez Pharmaceuticals, Inc. for making false and misleading claims in the promotional materials of its heart failure drug …